Evaluation of the effect of oral prolive on liver function in patients with major and intermediate thalassemia
Phase 3
Recruiting
- Conditions
- Major and intermedia thallassemia.Other disorders of blood and blood-forming organs in diseases classified elsewhere
- Registration Number
- IRCT20191010045050N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All patients with beta thalassemia major and intermedia over 5 years
Exclusion Criteria
Patients not willing to participate in the study
Malignancy
Liver dysfunction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver enzyme. Timepoint: Before the intervention and after, every one month to six months. Method of measurement: Laboratory.;Total Billirubin and Total protein. Timepoint: Before the intervention and after, every one month to six months. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method